Lifestyle
- Maintain adequate hydration
- Regular exercise
- Monitor protein intake
BUN · Blood Urea Nitrogen · Urea · Harnstoff-N
Blood urea nitrogen (BUN) measures the concentration of urea in the blood, reflecting protein metabolism and renal function.
Reference ranges may vary slightly based on laboratory standards and patient demographics.
Urea, also known as blood urea nitrogen (BUN), is a waste product formed in the liver through the urea cycle, where ammonia is converted into urea. This process is crucial for the detoxification of ammonia, a byproduct of protein metabolism. Urea is then transported in the blood to the kidneys, where it is excreted in urine. Researchers have long used BUN as a marker for assessing renal function, as it reflects the kidney's ability to filter waste products from the blood. Elevated BUN levels can indicate impaired kidney function or other conditions affecting the urea cycle. Clinically, BUN is an important marker for diagnosing and monitoring renal diseases, such as acute kidney injury and chronic kidney disease. It is also used to evaluate the severity of conditions like severe acute pancreatitis, where elevated levels may predict complications and mortality. In the context of athletic performance and biohacking, BUN levels can provide insights into protein metabolism and hydration status. Athletes and biohackers may monitor BUN to optimize protein intake and kidney health. However, BUN levels can be influenced by factors such as diet, hydration, and muscle mass, which may confound results. Therefore, it is important to consider these factors when interpreting BUN levels, and fasting or standardized testing conditions may be recommended to reduce variability.
Klinische Bedeutung
Elevated BUN levels may indicate renal dysfunction, dehydration, or increased protein catabolism. Low BUN levels can suggest liver dysfunction or malnutrition.
Progressively rising BUN levels suggest worsening renal function or dehydration. Retest in 4 weeks if levels are outside the optimal range.
Progressively falling BUN levels may indicate improved hydration or dietary changes.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before making significant dietary or lifestyle changes, especially if kidney function is impaired.
BUN levels can vary throughout the day; testing at the same time is recommended for consistency.
Testing Frequency
Annually for healthy adults, more frequently if monitoring kidney function.
Correlated with
Current research suggests that reference ranges and optimal targets for blood urea nitrogen (BUN) remain debated, particularly in the context of acute kidney injury and severe acute pancreatitis, where confounding factors may affect its predictive value. Emerging research directions include the identification of novel urinary biomarkers for renal injury and the development of non-invasive ammonia detection methods. However, clinical questions regarding the sensitivity and specificity of these biomarkers in diverse populations remain unanswered.
693
Total Citations
29
Human/RCT
2.6
Avg. Influence
2026
Latest
This study highlighted blood urea nitrogen (BUN) as a potential biomarker for neurohormonal activation in heart failure. Researchers noted that BUN levels could indicate renal response to neurohormonal changes, suggesting its relevance in heart failure management.
Researchers observed that vancomycin combined with piperacillin-tazobactam increased creatinine levels but did not significantly affect blood urea nitrogen (BUN) or other kidney biomarkers. This suggests that changes in creatinine may represent pseudotoxicity rather than true kidney injury.
This study examined the relationship between serum creatinine and blood urea nitrogen (BUN) levels in assessing kidney function. Researchers found that while both markers are useful, serum creatinine is less influenced by external factors and provides a more accurate evaluation of renal health.
Researchers found that diabetic nephropathy (DN) in rats was associated with increased blood urea nitrogen (BUN) and serum creatinine levels, indicating kidney injury. The study identified novel biomarkers that could aid in the early detection of DN.
Researchers conducted a systematic review on renal changes in COVID-19 patients. The review found that increased blood urea nitrogen (BUN) levels were common in patients with acute kidney injury (AKI), indicating significant renal impact from the virus.
Researchers found that blood urea nitrogen (BUN) levels were significantly higher in patients with severe acute pancreatitis who did not survive compared to those who did. The study indicated that BUN could serve as an independent risk factor for mortality, with a specific cutoff value predicting 30-day all-cause mortality.
This study explored the relationship between blood urea nitrogen (BUN), albumin, and mortality risk in COVID-19 patients. Researchers found that elevated BUN levels were associated with increased in-hospital mortality, suggesting BUN could be a reliable predictor of clinical outcomes in COVID-19 cases.
Researchers reviewed laboratory biomarkers for predicting severe COVID-19 disease. They highlighted that blood urea nitrogen (BUN) levels are important indicators of kidney function and disease severity in COVID-19 patients.
4
Total Trials
668
Total Enrolled
Tongji Hospital
40
2025
Mean blood ammonia levels at month 3 after enrollment.
Global Health Uganda LTD
270
2021
The frequency, age specific prevalence and severity of Sickle Cell Vasculopathy manifested by New stroke as assessed by the Pediatric NIH Stroke Scale (PedNIHSS) over the 3-year study while on hydroxyurea treatment, compared to baseline assessments.
Chang Gung Memorial Hospital
288
2021
The rate of early neurological improvement at 72 hours after the onset of stroke
Baylor College of Medicine
70
2013
Time to patients reaching the maximum tolerated dose (MTD) of the medication
Research publications about Harnstoff over time
8totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer